Regulatory T cells (T regs ) play an integral role in the adaptive immune system through suppression of selfreactive immune responses in order to prevent autoimmunity and maintain homeostasis. However, they are deleterious in cancer through suppression of the antitumor immune response. In fact, we show that deletion of 50% of T regs results in normal tumor growth. Therefore, it is advantageous to understand the role of T regs in the tumor microenvironment in order to create targeted cancer therapies. Our lab has shown that the Neuropilin-1 (Nrp1) pathway is required for T reg stability in the tumor microenvironment, but is disposable for maintaining immune homeostasis in the periphery, identifying it as a prime therapeutic target.
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In order to further understand the role of Nrp1-deficient T regs intratumorally, we constructed a competitive environment by utilizing Foxp3, which is located on the X chromosome, and as a result of X-inactivation, female Foxp3 Cre-YFP heterozygous mice are cellular heterozygotes. We generated Nrp1 L/L Foxp3 Cre-YFP/+ heterozygous mice comprised of 50% WT T regs and 50% Nrp1-deficient T regs . Surprisingly, when given B16 melanoma, heterozygous mice phenocopyNrp1 L/L Foxp3 Cre-YFP homozygous mice ( Figure 1A ). This suggests that Nrp1-deficient T regs are playing an active role in shifting the anti-tumor immune response by destabilizing surrounding WT T regs as determined by DNA methylation status ( Figure 1B) . Neither WT nor Nrp1-deficient T regs in the tumor from Nrp1 L/L Foxp3 Cre-YFP/+ mice can suppress in a standard microsuppression assay ex vivo, unlike WT T regs from Foxp3 Cre-YFP mice. Through various co-culture experiments, we revealed that destabilization of WT T regs University of Pittsburgh, Pittsburgh, PA, USA is possibly due to a soluble factor derived from Nrp1deficient T regs . Our data revealed that Nrp1-deficient T regs produce large amounts of IFNγ in the tumor microenvironment. Indeed, when treated with IFNg, WT T regs lose suppressive capacity. In order to uncover potential novel pathways leading to this phenotype, we are performing global transcript studies using RNASeq. Overall, we have shown that Nrp1 is required for intratumoral T reg stability, and in its absence, there is an alteration in the tumor microenvironment, leading to an enhanced anti-tumor immune response. These studies uncover a novel potential target for future cancer immunotherapies that preserves peripheral immune health. 
